Company News

Galderma Acquires Spirig of Switzerland

Products treat solar damage, skin carrier function impairment.

Author Image

By: TOM BRANNA

Editor

Galderma Pharma S.A has acquired Spirig, a leading Swissdermatological products producer that recordedsales of approximately $105 million in 2011. Spirig’s products treat conditions such as solar damage and skin barrier function impairment.In addition, the company has a range of medically-proven products that prevent pre-cancerous conditions, such as actinic keratosis, a type of non-melanoma skin cancer. Leading brands include Excipial, Daylong and Daylong Actinica. “We are...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters